Obesity is a worldwide threat, affecting both developed and developing countries. Guggulipid obtained from gum guggul is widely prescribed in Ayurveda for various medical conditions including obesity. The present study was designed to investigate the effect of guggulsterone on the expression of adiponectin, the adipokine that regulates glucose and fatty acid metabolism. 3T3-L1 cells were treated with guggulsterone E / Z isomer [(GE) /(GZ)] and mRNA levels of adiponectin as well as PPAR (a transcription factor that regulates adiponectin expression) were monitored. Treatment of 3T3-L1 cells with GE / GZ during differentiation into adipocytes led to reduced mRNA levels of adiponectin. However, no effect on the mRNA levels of adiponectin was observed when fully differentiated adipocytes were treated with either GE or GZ.
Prevalence of obesity is on the rise globally, with around 1.4 billion overweight adults including 500 million obese people (WHO report 2014) [1] . Obesity is associated with a number of health problems, including Type 2 diabetes. Dyslipidemia, such as elevated levels of triglycerides, high cholesterol and reduced levels of HDL, is common in Type 2 diabetes [2] . Guggulipid is recommended in Indian traditional medicine for hypercholesterolemia, inflammation, atherosclerosis and obesity [3] [4] [5] . Guggulsterone enhanced transcription of bile salt export pump [6] and is shown to be antagonistic to farnesoid X receptor [7] . Extensive studies have been carried out to evaluate the effectiveness of guggulipid on lipid profiles [8] .
Adiponectin is the most abundant adipokine secreted exclusively by adipose tissue. Production of adiponectin is induced in adipocytes during their differentiation [9] . This hormone regulates glucose and lipid metabolism [10] . Hypo-adiponectinemia correlates with obesity, diabetes and insulin resistance [11] . Expression of high levels of endogenous adiponectin improved insulin sensitivity in mice [12, 13] . Adiponectin inhibited lipolysis in murine adipocytes [14] . PPARγ transcription factor is essential for the pre-adipocyte to differentiate into mature adipocyte [15, 16] . It induces transcription of several genes including adiponectin [17] . In 3T3-L1 cells, guggulsterone decreased expression of PPARγ [18] . Since guggulipid is extensively prescribed in traditional medicine and that its active ingredient, the guggulsterone, was shown to downregulate the transcription factor PPAR, the present study aimed to investigate the influence of guggulsterone (E-and Z-isomers) on the expression adiponectin which is linked with insulin sensitivity and obesity [21] .
The objective of this study was to check whether guggulsterone has any effect on mature and differentiating adipocytes in terms of expression of adiponectin. Initial experiments were conducted to check viability of adipocytes in presence of guggulsterone: fully differentiated 3T3-L1 adipocytes (mature cells which were on their 14th day of differentiation) were treated with GE or GZ isomer (25 µM, 50 µM and 100 µM) for 24 hours. Control cells were treated with equal volume of the DMSO minus guggulsterone. Guggulsterone was cytotoxic to the cells in a dose-dependent manner. GZ caused more cell death than GE isomer (Figure 2 ). The viability of the differentiating adipocytes in presence of GE/GZ (from day 0-day 3 / from day 0-day 6) was checked, which showed that cytotoxicity levels were same for 0-3 day and 0-6 day treatments.
To test whether guggulsterone has any effect on the expression of adiponectin, treated cells were analyzed for protein levels. Adiponectin levels did not significantly change compared to DMSO treated controls ( Figure 3A ) in fully matured adipocytes (treated for 24 hrs with GE/GZ). In differentiating adipocytes [pre-adipocytes were treated at their initial stages of differentiation for 3 days (day 0-3) or for 6 days (day 0-6)] treatment with GE/GZ reduced adiponectin levels in concentration dependent manner ( Figure 3B and C). In summary, GE / GZ did not affect the adiponectin levels in mature adipocytes, but reduced adiponectin levels if treated while adipocytes were undergoing differentiation. PPAR transcriptional factor plays a significant role in adipocyte differentiation by transactivating several target genes [22] including that of adiponectin. In order to check whether adiponectin regulation by gugglesterone is due to general modulation in the expression of PPAR, we analyzed mRNA levels of both adiponectin and PPAR. In mature adipocytes GE or GZ did not have any marked effect on the mRNA levels of PPAR or adiponectin ( Figure 4A ). Whereas, in differentiating adipocytes, there was considerable reduction of mRNA levels of both adiponectin and PPAR ( Figure 4B and C), indicating that both follow similar pattern of expression. There is sufficient evidence to state that expression of adiponectin is induced by PPAR (PPAR response elements were detected in the adiponectin gene). PPAR agonists caused elevated levels of adiponectin [15, 17] . It has been previously reported that Guggul down regulates this transcription factor. In this context it is important to know whether guggul influence adiponectin expression as maintenance of normal levels of adiponectin is essential. Our study reveals that guggulsterone down regulates adiponectin and that mRNA level of both PPAR and adiponctin followed same pattern.
This study demonstrates that guggulsterone has no effect on the expression of adiponectin in already differentiated mature adipocytes, but considerably reduced adiponectin levels in differentiating adipocytes. These results can be further substantiated in mouse models to demonstrate utility of guggulsterone as possible therapeutic agent. Culture and differentiation of 3T3L1 cells: 3T3-L1 cells (NCCS, Pune) were grown in adipocyte 'growth medium' (DMEM + 4.5g/ L glucose, 0.58 g/L Glutamine, 0.1% Gentamycin and 10% FBS). Forty-eight hours after attaining confluency, 'differentiation medium' [growth medium + 1.0 µM Dexamethasone, 0.5 mM Methyl isobutyl xanthine (IBMX) and 1.0 µg/mL Insulin (sigma)] was added (on day 0) for three days. The cells were then maintained in 'maintenance medium' (growth medium + 1.0 µg/mL Insulin) until 14th day [19] . Cells were collected, washed and frozen in -80°C till further use.
Induction of cells with guggulsterone:
Stock solutions (100x) of Guggulsterone were prepared in DMSO and were added (25 µM, 50 µM and 100 µM) to the adipocytes (0-3 days or 0-6 days of differentiation /to the fully differentiated adipocytes for 24 hrs) (day 0 = day of addition of the differentiating medium). Corresponding volume of DMSO was added to the control wells. Triplicates were maintained for each concentration and each experiment was repeated twice.
Cell viability assay: 3T3-L1 cells were cultured in 96-well plates, differentiated into mature adipocytes and were treated with Guggulsterone-E or -Z in three different concentrations (25 µM, 50 µM, 100 µM) for 24-hours. Control cells were treated with corresponding volume of DMSO. At the end of treatment, 10 µL of MTT reagent was added (final concentration of 10%) and incubated for 3 hours at 37°C. The formazan crystals formed were dissolved in 100 µL of DMSO and absorbance was measured at 560 nm and 670nm. The average of both readings was taken. Similarly, cytotoxicity of the gugglesterone was assayed by treating the differentiating adipocytes for 0-3 days or 0-6 days.
Detection and quantification of Adiponectin by western blotting:
Cells were washed and lysed in 0.5 M Tris -HCl buffer, pH 7.4, containing 1 mM EDTA, 5 mM DTT and Protease inhibitor cocktail. Lysates were subjected to ultrasonication and centrifugation. Total Protein was estimated by Lowry method. For SDS-PAGE, 10% running gels and 4.6% stacking gels were used (Biorad Mini-PROTEAN® Tetra Cell). Duplicate gels were run simultaneously, one gel was used for Coomassie staining and the other gel for western blotting.
The SDS-PAGE gels were blotted on to PVDF membranes by semi dry electro-transfer (Pierce™ Power Blotter) (Thermo ScientificPierce Protocol) for 7 minutes at 11Volts. Prior to transfer, the PVDF membranes were wetted in methanol for 5 minutes and were equilibrated in 1-Step transfer buffer (thermo Scientific-Pierce) for 10 min. After the completion of the transfer, the membranes were immersed in TE buffer containing 5 % BSA (10 mM Tris-Cl, pH -7.4, 150 mM NaCl) for 1 hr at RT and then in anti-adiponectin antibody solution [Adipo R1 (C-14) Santa Cruz Biotechnology Cat no. sc-46748], overnight at 4°C. The membrane was washed 3 times (TE buffer containing 0.05% tween-20), incubated in secondary antibody solution (anti-IgG HRP conjugate, Sigma Cat no A5420) for one hour at 37°C, washed and reacted with TMB substrate. The experiment was conducted twice.
Quantitative PCR: Total RNA from cells (treated with GE or GZ or DMSO) was isolated using geniPureTM total RNA isolation kit (cat no. 612117100021730, MERCK) as per the manufacturer's protocol. RNA was quantified and equal amount of RNA was taken for cDNA synthesis (high capacity cDNA Reverse Transcription Kit, Applied Biosystems cat no. 4368814). Quantitative PCR was performed using Roche LightCycler® Real-Time PCR System. Primers used for Adiponectin, PPAR and GAPDH were: Adipo F 5'-AGCCGCTTATGTGTATCGCTCA, AdipoR 5'-TGCCGTCAT AATGATTCTGTTGG, PPAR- F 5'-GCCCTTTGGTGACTTT ATGGA, PPAR-R5'-GCAGCAGGTTGTCTTGGATG, GAPDH-FP 5'-GGCTGCTTTTAACTCTGGCAAA and RP-5'GTGGGTAGAATCATACTGGAACATGT.
